Fab'entech's Series A Round

Fab'entech raised a round of funding on June 24, 2014.

Fab'entech is a biopharmaceutical company which develops and commercializes a range of innovative passive immunotherapeutic solutions based on specific polyclonal immunoglobulins in the field of emerg…

Articles about Fab'entech's Series A Round: